H.C. Wainwright Starts Scribe Therapeutics Inc (SCTX) at Buy
Tweet
Share
E-mailGet Alerts SCTX Hot Sheet
Price: $28.44 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 25
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 25
Join SI Premium – FREE
H.C. Wainwright initiates coverage on Scribe Therapeutics Inc (NASDAQ: SCTX) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Scribe Therapeutics Inc click here. For more ratings news on Scribe Therapeutics Inc click here.
Shares of Scribe Therapeutics Inc closed at $28.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts River City Bank (RCBC) at Outperform
- AGCO opens 115,000-square-foot parts distribution center in Visalia
- salesforce.com (CRM) PT Raised to $300 at Argus
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
